Coronary artery disease investigated using 99mTc-tetrofosmin myocardial SPECT. 2007

T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
Department of Internal Medicine, Enshu Hospital, Hamamatsu, Japan.

BACKGROUND Coronary artery disease can be diagnosed from stress and delayed images of myocardial single photon emission computed tomography (SPECT) using technetium-99 m-tetrofosmin (TcTF). However, the negative predictive value of stress SPECT images after a single injection of a low tracer dose remains unknown. Thus, the present study investigates whether normal stress SPECT results predict event-free survival. METHODS We screened 302 consecutive patients who were randomly assigned to two groups for myocardial ischaemia using either stress SPECT with a low dose of TcTF (296 MBq, TcTF group, n = 150) or stress together with rest SPECT using thallium(201) chloride (TlCl, 111 MBq; TlCl group, n = 152) as the tracer. A total of 80 patients with abnormal SPECT findings were excluded and the remaining 222 with normal results (age, 66.5 +/- 0.7 years; TcTF/TlCl, 112/110) were enrolled in the present study and followed up for 401 +/- 9 days, with the endpoint being ischaemic cardiac events. RESULTS The incidence of cardiac events did not differ between the two groups (0.9% and 0.0% in TcTF and TlCl groups, respectively). The cost and duration of TcTF and TlCl SPECT examinations were about 425 and 603 Euros and 50 and 280 min, respectively. CONCLUSIONS The negative predictive values of stress SPECT using a low dose of TcTF and of combined stress and rest SPECT using TlCl did not differ and both were clinically acceptable. Thus, stress SPECT using low dose TcTF is useful in screening patients for myocardial ischaemia.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015899 Tomography, Emission-Computed, Single-Photon A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. CAT Scan, Single-Photon Emission,CT Scan, Single-Photon Emission,Radionuclide Tomography, Single-Photon Emission-Computed,SPECT,Single-Photon Emission-Computed Tomography,Tomography, Single-Photon, Emission-Computed,Single-Photon Emission CT Scan,Single-Photon Emission Computer-Assisted Tomography,Single-Photon Emission Computerized Tomography,CAT Scan, Single Photon Emission,CT Scan, Single Photon Emission,Emission-Computed Tomography, Single-Photon,Radionuclide Tomography, Single Photon Emission Computed,Single Photon Emission CT Scan,Single Photon Emission Computed Tomography,Single Photon Emission Computer Assisted Tomography,Single Photon Emission Computerized Tomography,Tomography, Single-Photon Emission-Computed
D017256 Technetium Tc 99m Sestamibi A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack. 99mTc-Hexamibi,99mTc-Sestamibi,Tc MIBI,Cardiolite,Tc-99m-Methoxy-2-isobutylisonitrile,Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile,Technetium Tc 99m Sestamibi Chloride,Technetium-99m-Hexamibi,Technetium-99m-Sestamibi,99mTc Hexamibi,99mTc Sestamibi,Tc 99m Methoxy 2 isobutylisonitrile,Technetium 99m Hexamibi,Technetium 99m Sestamibi,Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
April 2003, Annals of nuclear medicine,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
January 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
January 2002, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
October 1999, Revista espanola de medicina nuclear,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
August 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
September 1995, Kaku igaku. The Japanese journal of nuclear medicine,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
April 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
October 1996, Nuklearmedizin. Nuclear medicine,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
March 2003, Nuclear medicine communications,
T Toriyama, and H Takase, and T Goto, and T Sugiura, and A Nakazawa, and K Hayashi, and H Ishikawa, and Y Hikita, and R Ueda, and Y Dohi
January 2009, Molecular imaging and biology,
Copied contents to your clipboard!